Deep Track Capital, LP Aligos Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 6,102,770 shares of ALGS stock, worth $3.05 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,102,770
Previous 6,102,770
-0.0%
Holding current value
$3.05 Million
Previous $4.03 Million
48.5%
% of portfolio
0.2%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding ALGS
# of Institutions
53Shares Held
46.2MCall Options Held
6.11MPut Options Held
200-
Armistice Capital, LLC New York, NY6.89MShares$3.45 Million0.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.39MShares$3.19 Million0.18% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$1.77 Million0.46% of portfolio
-
Altitude Crest Partners Inc. Stamford, CT2.84MShares$1.42 Million1.19% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.46MShares$1.23 Million0.0% of portfolio
About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $19.9M
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...